NovoCure Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	93.7	93.55	163.77	240.82	115.33	208.8
Short-Term Investments	346.86	354.13	796.11	669.8	854.1	728.9
Cash & Short-Term Investments	440.56	447.67	959.87	910.62	969.43	937.7
Cash Growth	-51.67%	-53.36%	5.41%	-6.07%	3.38%	11.29%
Accounts Receivable	99.13	89.44	74.23	61.22	86.26	93.57
Other Receivables	46.69	58.67	35.06	22.68	25.96	17.03
Total Trade Receivables	145.82	148.1	109.29	83.9	112.22	110.59
Inventory	42.22	41.11	35.09	38.15	29.38	24.43
Other Current Assets	9.92	9.84	2.33	1.74	0.51	0.81
Total Current Assets	638.52	646.73	1,107	1,034	1,112	1,074
Net Property, Plant & Equipment	145.74	147	119.59	97.7	68.96	53.88
Other Long-Term Assets	10.93	10.6	14.62	14.02	11.16	12.09
Total Assets	795.19	804.33	1,241	1,146	1,192	1,139
Accounts Payable	130.73	122.23	105.09	94.39	85.2	72.6
Accrued Expenses	89.98	101	93.15	84.72	73.58	70
Current Portion of Long-Term Debt	-	-	558.16	-	-	-
Total Current Liabilities	220.71	223.23	756.39	179.12	158.78	142.6
Long-Term Debt	195.89	195.05	97.3	568.82	565.51	562.22
Long-Term Leases	37.53	41.65	19.97	27.42	18.76	13
Other Long-Term Liabilities	2.97	3.94	6.94	8.28	7.43	11.19
Total Long-Term Liabilities	236.39	240.63	124.21	604.52	591.7	586.4
Total Liabilities	457.1	463.86	880.61	783.63	750.48	729
Additional Paid-in Capital	1,719	1,634	1,520	1,353	1,222	1,100
Accumulated Other Comprehensive Income	-3.42	-3.44	-5.5	-5.47	-2.43	-3.17
Retained Earnings	-1,377	-1,290	-1,154	-985.5	-778.46	-685.93
Shareholders' Equity	338.09	340.47	360.18	362.5	441.17	410.49
Total Liabilities & Equity	795.19	804.33	1,241	1,146	1,192	1,139
Total Debt	233.42	236.69	675.43	596.24	584.27	575.21
Net Cash (Debt)	207.14	210.98	284.44	314.37	385.15	362.49
Net Cash Growth	-1.96%	-25.83%	-9.52%	-18.38%	6.25%	-9.01%
Net Cash Per Share	1.82	1.89	2.64	2.96	3.68	3.47
Book Value	338.09	340.47	360.18	362.5	441.17	410.49
Book Value Per Share	2.98	3.05	3.34	3.41	4.22	3.93
Tangible Book Value	338.09	340.47	360.18	362.5	441.17	410.49
Tangible Book Value Per Share	2.98	3.05	3.34	3.41	4.22	3.93

SEC Filings: 10-K · 10-Q